-
UK pharma contributes £190m to NHS meds bill
pharmatimes
October 31, 2017
The UK pharmaceutical industry has paid the Department of Health £190 million during the first two quarters of 2017 under the 2014 Pharmaceutical Price Regulation Scheme (PPRS).
-
NHS was crippled by “unsophisticated” cyber attack
pharmafile
October 30, 2017
Back in May of this year, the NHS was hit by a cyber attack that severely impacted at least 34% of trusts across England.
-
NHS patients could be offered Airbnb-like accommodation
pharmafile
October 27, 2017
In a sign of how desperate the hospital bed situation across the UK is, one council has looked into piloting an AirBnb-style solution.
-
Worrying number of organ donations blocked by families
pharmafile
October 20, 2017
A report from the BBC has found that 505 registered organ donors had their decision blocked by relatives, over the past five years. Last year, 457 people died last year waiting for an organ transplant.
-
New studies point to cracks forming in NHS services
pharmafile
October 19, 2017
Two studies published separately by the BBC and the Care Quality Commission (CQC) point to growing problems across NHS services in the UK.
-
‘No-deal’ Brexit could cost NHS £500m a year
pharmatimes
October 18, 2017
A ‘no-deal’ Brexit that ends healthcare arrangements between the UK and the EU could end up costing the NHS as much as £500 million a year
-
Health and care leaders fear winter will cripple NHS
pharmatimes
October 13, 2017
More than 90 percent of health and care leaders across England say they are “concerned” about their organisation's ability to cope with demand this winter, with the majority (63 percent) citing “extreme” concern.
-
Future quality of NHS and social care is ‘precarious’, says CQC
pharmatimes
October 11, 2017
The future of the health and social care system is in peril as it struggles to cope with the increasingly complex needs of a 21st century population, the Care Quality Commission has warned.
-
Improved heart attack test could save millions for NHS
pharmafile
September 28, 2017
A new research, funded by the British Heart Foundation, has led to the creation of a new heart attack test that could potentially save millions across the NHS.
-
Sanofi’s Kevzara will be funded for NHS use
pharmatimes
September 25, 2017
Some patients with rheumatoid arthritis living in England and Wales should get ‘routine’ NHS access to Sanofi’s Kevzara after cost regulators issued draft guidelines deeming the drug cost effective.